PAVmed Inc. — Director's Dealing 2023

Apr 14, 2023

SEC Form 4/A — Form 4/A

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-11-30

Reporting Person: PAVmed Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-30	Common stock	J	1145086	$1.8383	Acquired	29072276	Direct
2022-11-30	Common Stock	J	197656	$2.7826	Acquired	29269932	Direct
2022-11-30	Common Stock	J	221952	$2.4780	Acquired	29491884	Direct
2022-11-30	Common Stock	J	331210	$1.6606	Acquired	29823094	Direct
2022-11-30	Common Stock	J	1479326	$1.8383	Acquired	31302420	Direct

Footnotes

F1: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement.

F2: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022.